Hansa Biopharma AB (publ)

Hansa Biopharma AB (publ)

HNSA.ST
Hansa Biopharma AB (publ)SE flagStockholm Stock Exchange
34.56
SEK
+0.26
- -
2.81BMarket Cap

Hansa Biopharma AB (publ) (HNSA.ST) Stock Split History

Learn about Hansa Biopharma AB (publ)'s most recent 263-for-250 basis stock split on March 16, 2015. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Hansa Biopharma AB (publ)'s most recent stock split

Split Date: 2015-03-16
Split Ratio: 263:250
Price Before Split: $50.39
Price After Split: $47.90

Developer API

Get HNSA.ST split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/HNSA.ST

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.05 times more shares (a 263:250 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Hansa Biopharma AB (publ)'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2015-03-16263:250No$50.39$47.90
2014-03-1957:56No$11.80$11.59
2011-05-17609:500No$8.85$7.27
2010-03-17227:200No$9.72$8.56

About Hansa Biopharma AB (publ)

Company overview and industry information

Hansa Biopharma AB (publ) (HNSA.ST) operates in the Biotechnology industry. The recent 263-for-250 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Biotechnology
Go to Hansa Biopharma AB (publ) Summary

Last updated: 7/8/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.